Associated criteria used in investigating suspected septic transfusion reactions: A scoping review.

blood safety criteria risk factors septic transfusion reactions transfusion medicine

Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 01 08 2023
received: 06 04 2023
accepted: 17 08 2023
pubmed: 11 9 2023
medline: 11 9 2023
entrez: 11 9 2023
Statut: ppublish

Résumé

Septic transfusion reactions (STRs) occur as a result of bacterial contamination of blood or blood products, resulting in sepsis. This scoping review aimed to identify, explore and map the available literature on the STR criteria triggering the investigation of STR. Four electronic databases (MEDLINE, Web of Science, Science Direct, Embase) were searched to retrieve scientific literature reporting such criteria, published from 1 January 2000 to 5 May 2022. Grey literature was also searched from open web sources. Of 1052 references identified, 43 (21 peer-reviewed and 22 grey literature) met the eligibility criteria for inclusion and data extraction after full article screening. Of them, most (27/43, 62.79%) were found to report a single set of criteria, and only two reported four or more sets of criteria. The analysis of 66 sets of criteria collected from the selected references revealed 57 different sets. A few sets of criteria used only one sign and symptom (s/s) (12.12%, n = 8), whereas 16 sets used 7-15 s/s (n = 16/66; 24.24%). Of the total 319 occurrences of s/s associated with the 66 sets of criteria, post-transfusion hyperthermia, body temperature increase and hypotension were the most common s/s categories. Of all the literature available, only one study tested the diagnostic accuracy of the STR criteria. This scoping review revealed a substantial variation in criteria used to identify suspected STR. Consequently, conducting further studies to enhance the diagnostic accuracy of these criteria, which trigger STR investigations, is imperative for advancing clinical practice.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Septic transfusion reactions (STRs) occur as a result of bacterial contamination of blood or blood products, resulting in sepsis. This scoping review aimed to identify, explore and map the available literature on the STR criteria triggering the investigation of STR.
MATERIALS AND METHODS METHODS
Four electronic databases (MEDLINE, Web of Science, Science Direct, Embase) were searched to retrieve scientific literature reporting such criteria, published from 1 January 2000 to 5 May 2022. Grey literature was also searched from open web sources.
RESULTS RESULTS
Of 1052 references identified, 43 (21 peer-reviewed and 22 grey literature) met the eligibility criteria for inclusion and data extraction after full article screening. Of them, most (27/43, 62.79%) were found to report a single set of criteria, and only two reported four or more sets of criteria. The analysis of 66 sets of criteria collected from the selected references revealed 57 different sets. A few sets of criteria used only one sign and symptom (s/s) (12.12%, n = 8), whereas 16 sets used 7-15 s/s (n = 16/66; 24.24%). Of the total 319 occurrences of s/s associated with the 66 sets of criteria, post-transfusion hyperthermia, body temperature increase and hypotension were the most common s/s categories. Of all the literature available, only one study tested the diagnostic accuracy of the STR criteria.
CONCLUSION CONCLUSIONS
This scoping review revealed a substantial variation in criteria used to identify suspected STR. Consequently, conducting further studies to enhance the diagnostic accuracy of these criteria, which trigger STR investigations, is imperative for advancing clinical practice.

Identifiants

pubmed: 37691585
doi: 10.1111/vox.13521
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1029-1037

Subventions

Organisme : Medical Affairs and Innovation, Héma-Québec, Montreal, Quebec, Canada
Organisme : Mitacs Accelerate Program, Quebec, Canada
ID : IT17135

Informations de copyright

© 2023 International Society of Blood Transfusion.

Références

Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. Transfusion-transmitted infections. J Transl Med. 2007;5:1479-5876.
Fong IW. Blood transfusion-associated infections in the twenty-first century: new challenges. In: Current trends and concerns in infectious diseases. Emerging infectious diseases of the 21st century. Cham: Springer Nature; 2020: p. 191-215.
Josephson CD. Chapter 59 - septic transfusion reactions. In: Hillyer CD, Shaz BH, Zimring JC, et al., editors. Transfusion medicine and hemostasis. San Diego: Academic Press; 2009. p. 335-338.
García-Otálora M-A, Núñez-Ahumada M-A, Kuperman S, Oliveira-Leitão L, Silveira F, Martins R, et al. Bacterial contamination and sepsis associated with transfusion: current status in Latin America. Ann Blood. 2021;2021:1-18.
Government of Canada. Transfusion Transmitted Injuries Surveillance System (TTISS): 2006-2012 Summary Results. [cited 2022 Aug 14]. Available from: https://www.canada.ca/en/public-health/services/surveillance/blood-safety-contribution-program/transfusion-transmitted-injuries-surveillance-system/2006-2012-summary-results.html#t_1a
de Korte D, Marcelis JH. Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections. Int J Clin Transfus. 2014;2:29-37.
Eder AF, Goldman M. How do I investigate septic transfusion reactions and blood donors with culture-positive platelet donations? Transfusion. 2011;51:1662-1668.
Levy JH, Neal MD, Herman JH. Bacterial contamination of platelets for transfusion: strategies for prevention. Crit Care. 2018;22:271.
Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Muylle L. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev. 2005;19:259-272.
Hong H, Xiao W, Lazarus HM, Good CE, Maitta RW, Jacobs MR. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood. 2016;127:496-502.
Jacobs MR, Good CE, Lazarus HM, Yomtovian RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis. 2008;46:1214-1220.
Sahu S, Verma A. Adverse events related to blood transfusion. Indian J Anaesth. 2014;58:543-551.
Shih AW, Cohn CS, Delaney M, Fontaine MJ, Martin I, Dunbar NM. The BEST criteria improve sensitivity for detecting positive cultures in residual blood components cultured in suspected septic transfusion reactions. Transfusion. 2019;59:2292-2300.
Acharya D, Lewin A, Gaussen A, Lambert G, Renaud C, Nawej K, et al. Study protocol of associated criteria used in investigating septic transfusion reactions (STRs): a scoping review about available evidence. PLoS One. 2022;17:e0262765.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097.
Delbosc A, Lafeuillade B, Petermann R, Eb F, Ounnoughene N. Les infections bactériennes transmises par transfusion avec imputabilité 2 du PSL: analyse rétrospective de la base e-FIT de 2000 à 2007. Transfus Clin Biol. 2011;18:26-35.
Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41:857-861.
Ruby KN, Khan J, Martin IW, Dunbar NM. Application of standardized residual component culture criteria for suspected septic transfusion reactions would increase the component culturing rate at a single academic medical center. Am J Clin Pathol. 2022;158:216-220.
Perez P, Rachid Salmi L, Follea G, Schmit JL, De Barbeyrac B, Sudre P, et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM case-control study. Transfusion. 2001;41:862-872.
American Association of Blood Banks (AABB). AABB classification of acute transfusion reactions noninfectious complications of blood transfusion. In: Brecher ME, editor. Technical manual. Bethesda: American Association of Blood Banks; 2005. p. 33-66.
American Association of Blood Banks (AABB). Clinical recognition and investigation of suspected bacterial contamination of platelets. 2014.
Australian Red Cross Lifeblood. Acute transfusion reactions. Australia. 2019.
Australian Red Cross Lifeblood. Common adverse reactions to blood products and guide to appropriate clinical action. Management of suspected reactions | Lifeblood Australia. 2021.
Fuller AK, Uglik KM, Savage WJ, Ness PM, King KE. Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion. 2009;49:2588-2593.
Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program. Investigation of adverse transfusion reactions. 2019.
Lafeuillade B, Eb F, Ounnoughene N, Petermann R, Daurat G, Huyghe G, et al. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008. Transfusion. 2015;55:636-646.
Lifeblood Australia. Blood book Australian blood administration handbook. Australia: Australian Red Cross Lifeblood; 2020.
Public Health Agency of Canada (PHAC). Guideline for investigation of suspected transfusion transmitted bacterial contamination. CCDR 2008: 34S1: 1-8. Canada, Public Health Agency of Canada (PHAC). 2008.
Serious Hazards of Transfusion (SHOT). Definitions of current SHOT reporting categories & what to report United Kingdom. 2022.
Ontario Transfusion Transmitted Injuries Surveillance System (TTISS-ON). Acute transfusion reaction chart. Canada. 2020.
American Red Cross. Interview of Dr Anne Eder by Dr Joe Chaffin-11 April 2016. 2014.
American Red Cross. US blood supply facts: facts about blood needs. Available from: https://www.redcrossblood.org/donate-blood/how-to-donate/how-blood-donations-help/blood-needs-blood-supply.html
Chew E, Benjamin RJ, McDonald CP, Wiersum-Osselton JC, Wood EM, on behalf of the International Society of Blood Transfusion Working Parties on Transfusion-Transmitted Infectious Diseases (Bacterial subgroup) and Haemovigilance Diseases. International survey on definitions and current practices in prevention, diagnosis, management and reporting of transfusion-transmitted bacterial infections. ISBT Sci Ser. 2015;10:31-40.
Graff L, Russell J, Seashore J, Tate J, Elwell A, Prete M, et al. False-negative and false-positive errors in abdominal pain evaluation failure to diagnose acute appendicitis and unnecessary surgery. J Acad Emerg Med. 2000;7:1244-1255.
Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493-1499.
Sanders RP, Geiger TL, Heddle N, Pui CH, Howard SC. A revised classification scheme for acute transfusion reactions. Transfusion. 2007;47:621-628.
Benjamin RJ, Kline L, Dy BA, Kennedy J, Pisciotto P, Sapatnekar S, et al. Bacterial contamination of whole blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion. 2008;48:2348-2355.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-1655.
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530-538.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801-810.
Hillis CM, Shih AW, Heddle NM. Best practices in the differential diagnosis and reporting of acute transfusion reactions. Int J Clin Transfus Med. 2016;4:1-14.
Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019;133:1840-1853.
Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. The Lancet. 2013;382:984-994.
Cohen R, Escorcia A, Tasmin F, Lima A, Lin Y, Lieberman L, et al. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions. Transfusion. 2017;57:1674-1683.
Martin IW, Cohn CS, Delaney M, Fontaine MJ, Shih AW, Dunbar NM, et al. Limitations of current practices in detection of bacterially contaminated blood products associated with suspected septic transfusion reactions. Transfusion. 2021;61:2414-2420.
Eder AF, Kennedy JM, Dy BA, Notari EP, Skeate R, Bachowski G, et al. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion. 2009;49:1554-1563.
Moncharmont P, Barday G, Meyer F, les Correspondants d'Hémovigilance Rhône Alpes. Transfusion-transmitted bacterial infection: a 2-year survey. Transfus Med. 2016;26:308-310.
Hamburg M. Bacterial contamination of platelets: report to congress in response to house of representatives report Washington, DC. 2012. pp. 112-542.
Erony SM, Marshall CE, Gehrie EA, Boyd JS, Ness PM, Tobian AAR, et al. The epidemiology of bacterial culture-positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016. Transfusion. 2018;58:1933-1939.
Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. Access to pathology and laboratory medicine services: a crucial gap. Lancet. 2018;391:1927-1938.
Fridey JL, Stramer SL, Nambiar A, Moayeri M, Bakkour S, Langelier C, et al. Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction. Transfusion. 2020;60:1960-1969.
Mafirakureva N, Khoza S, Mvere DA, Chitiyo ME, Postma MJ, Van Hulst M. Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis. Blood Transfus. 2014;12:362-367.

Auteurs

Dilaram Acharya (D)

Department of Management, Evaluation and Health Policy, School of Public Health, Université de Montréal, Montréal, Québec, Canada.
Medical Affairs and Innovation, Héma-Québec, Montréal, Québec, Canada.

Amaury Gaussen (A)

Medical Affairs and Innovation, Héma-Québec, Montréal, Québec, Canada.

Thomas G Poder (TG)

Department of Management, Evaluation and Health Policy, School of Public Health, Université de Montréal, Montréal, Québec, Canada.
Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal, CIUSSS de l'Est-de-L'île-de-Montréal, Montréal, Québec, Canada.

Gilles Lambert (G)

Direction régionale de santé publique, Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal du Québec, Montréal, Québec, Canada.
Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Montréal, Québec, Canada.

Christian Renaud (C)

Medical Affairs and Innovation, Héma-Québec, Montréal, Québec, Canada.

Karlitaj Nawej (K)

Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Montréal, Québec, Canada.

Antoine Lewin (A)

Medical Affairs and Innovation, Héma-Québec, Montréal, Québec, Canada.
Faculty of Medicine and Health Science, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Classifications MeSH